Sign up to our newsletter Subscribe
Understanding the Full Value of Long-Acting Therapies: less is more?
Join OHE for Its 50th Anniversary Annual Lecture with Sir Michael Rawlins
Every year, OHE sponsors a lecture by an eminent economist or clinician that addresses an important current issue. Sir Michael Rawlins Every year, OHE sponsors a lecture by an eminent economist or clinician that addresses an important current issue.…
Share:
Every year, OHE sponsors a lecture by an eminent economist or clinician that addresses an important current issue.
Sir Michael Rawlins
Every year, OHE sponsors a lecture by an eminent economist or clinician that addresses an important current issue. This year we are pleased to welcome Prof. Sir Michael Rawlins, who argues against reliance on randomized clinical trials as the "gold standard", instead urging a more pragmatic approach.
Sir Michael's experience – as a clinician, chair of the Committee on Safety of Medicines, and chair of NICE — uniquely qualifies him to address these issues.
July 2013 editor's note: click here for OHE's publication based on this lecture.
